Continuous phenobarbital showed no clear difference in recurrent seizure at 18 months compared with placebo or no treatment (moderate certainty).
Continuous phenobarbital probably leads to lower recurrent seizure at 24 months compared with placebo or no treatment (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether continuous phenobarbital changes recurrent seizure at 60 months or greater compared with placebo or no treatment (very low certainty).
Continuous phenobarbital probably leads to lower recurrent seizure at 6 months compared with placebo or no treatment (moderate certainty).
Continuous phenobarbital may leads to lower recurrent seizure at 12 months compared with placebo or no treatment (low certainty).
The findings closest to your search, judged one by one by TypeSafe's Jev model.